CGTBiologicArtiva Biotherapeutics, Inc.sPhase 1
NK cells/Combined Monoclonal Antibodies (NK cells/Combined Monoclonal Antibodies)
Hematological Malignancies · Hematological Malignancies
#HematologicalMalignancies#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 25%임상시험 48상태 RECRUITING